WO1995009662A1 - Instrument de sondage - Google Patents

Instrument de sondage Download PDF

Info

Publication number
WO1995009662A1
WO1995009662A1 PCT/US1993/009501 US9309501W WO9509662A1 WO 1995009662 A1 WO1995009662 A1 WO 1995009662A1 US 9309501 W US9309501 W US 9309501W WO 9509662 A1 WO9509662 A1 WO 9509662A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
dilator
surgical instrument
hub
sheath
Prior art date
Application number
PCT/US1993/009501
Other languages
English (en)
Inventor
Ravindar Jagpal
Original Assignee
Ravindar Jagpal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/919,912 priority Critical patent/US5257979A/en
Priority claimed from US07/919,912 external-priority patent/US5257979A/en
Application filed by Ravindar Jagpal filed Critical Ravindar Jagpal
Priority to PCT/US1993/009501 priority patent/WO1995009662A1/fr
Priority to AU53522/94A priority patent/AU5352294A/en
Publication of WO1995009662A1 publication Critical patent/WO1995009662A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06—Body-piercing guide needles or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0111—Aseptic insertion devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06—Body-piercing guide needles or the like
    • A61M25/0662—Guide tubes

Definitions

  • the present invention relates to surgical instruments and, in particular, to a universal instrument for the introduction of a catheter, cannula or tool into any part of the body.
  • the instrument allows diagnosis and treatment of disease using the same procedure.
  • the instrument includes a needle, syringe, Y chamber, guide- wire, dilator, sheath, shock sheath and protective sleeve. Methodology for discriminatory treatment of disease using embodiments of said instrument is described.
  • Universal may be used anywhere in or on the body
  • - may be used for diagnosis or treatment of disease
  • - may be used for temporary or permanent devices
  • - may be used by health care personnel in different fields of health care.
  • Discriminatory - treatment is focused on the diseased part(s) of the body so that systemic toxicity is markedly reduced (e.g. chemotherapeutic agents, external radiation, etc.).
  • Diagnosis includes tool, instrument, cannula or other device. Diagnosis (includes, but is not limited to):
  • specimens for study e.g., blood, pleural fluid, tissues, etc.
  • Treatment includes, but is not restricted to:
  • - drainage i.e., pus, urine, other fluids and substances
  • - infusion i.e, fluids, chemicals and other substances
  • blood vessel is used as an illustration only and is not by way of limitation for the scope of the present invention.
  • an instrument for catheterization was a tubular object used to drain noxious material (e.g. pus) from the body.
  • the instrument had a proximal end, generally sharp, to allow penetration of tissue or of a body structure, a tubular shaft with a lumen, and an open distal end to allow drainage and introduction of other substances and devices.
  • This instrument has evolved to a plethora of devices (e.g. needles, catheters of different types, cannulae, and biopsy tools, etc.) for catheterization of structures. Each of these has its own specific use(s), method of insertion, problems and complications.
  • Catheterization of a blood vessel will be used as an illustration. Catheters for blood vessels were initially developed for insertion into peripheral vessels, those which the practitioner could see and/or feel, e.g. on the dorsum of the hand or along the arm. With advances in medicine, it became necessary to catheterize larger blood vessels, many of which were neither visible nor palpable. This required a change in the procedure of catheterization. Several special- purpose catheters and insertion kits (described hereinafter) have become available for the diagnosis and treatment of medical problems. However, problems still exist during and after catheterization. It is one object of this invention to correct these problems.
  • - can be used both endoscopically and on the surface of the body; - can be used for diagnosis and treatment in all parts of the body using the same procedure.
  • This invention rectifies old problems and eliminates some of the newer ones (e.g. risk of AIDS by transmission of the HIV virus from patient to practitioner or vice-versa) .
  • the invention described here is a universal system. It is also a discriminatory system because it allows a system of treatment that is less toxic to the patient, hence more humane. This system requires fewer hospitalizations and is therefore less expensive. It is more efficient in diagnosis and allows appropriate therapy to be initiated during the same procedure.
  • catheterization of the subclavian vein requires the following steps:
  • the catheter is threaded over the guide-wire into the blood vessel.
  • the infusion lines are attached to the ports of the catheter.
  • Air embolism can also occur with only a guide-wire in place using the traditional method of catheterization.
  • the present invention rectifies this problem.
  • kits have a guide-wire with a "j" tip.
  • This requires a “feeder” or “straightener” to be attached at the hub of the needle so that the "j" tip is straightened temporarily, thus allowing the guide-wire to be inserted through the needle.
  • This can be a troublesome process and the "feeder” becomes unsterile as it falls off the sterile field.
  • the needle tip can get dislodged from the lumen of the blood vessel.
  • the present invention rectifies the problem.
  • Another problem frequently encountered during insertion of the guide-wire is that the direction of the bevel of the needle is not known. Hence the wire can travel in a direction other than that desired by the practitioner. This results in inappropriate positioning of the guide-wire and consequently, of the catheter.
  • 4,327,723 attempts to combat the problem of infection by the use of a Protective Sleeve.
  • the source of infection i.e., skin to catheter/introducer to bloodstream
  • infection continues to be a problem.
  • the catheter is inserted through the introducer lumen. This has the following potential problems:
  • Clot can form around the catheter if the side- port is not being used. Clot is a good medium for bacterial growth. Hence there is a likelihood of infection.
  • dextrose-rich fluids are infused through the side-port and bathe the catheter. This also assists bacterial growth.
  • problems pertaining to the diagnosis of disease using catheterization include inability to diagnose (e.g. insufficient tissue for diagnosis; tissue obtained is not from the diseased area) . Multiple procedures are performed unnecessarily, the patient is subjected to repeated trauma and risks and valuable time and money are wasted. Treatment of many diseases is non-discriminatory
  • medications are introduced systemically into the bloodstream so that all parts of the body, whether diseased or not, are exposed to these substances.
  • a large number of agents used in the treatment of cancer are very toxic.
  • the amounts of these medications that are administered are relatively large due to their subsequent dilution in the body. Were these agents administered primarily to target sites, smaller amounts of the therapeutic agents would be required with less toxicity and "healthy" parts of the body would not be damaged.
  • diagnosis and treatment of diseases is not possible during the same procedure.
  • U.S. Patent No. 4,192,302 provides a discriminatory method for treatment of liver cancer.
  • a complex shunt is described to isolate the target organ from the rest of the circulation.
  • the shunt treats the blood from the target organ with a chemotherapeutic agent extracorporeally then detoxifies the blood before returning it to the general circulation.
  • This requires hospitalization and a major operation each time treatment is administered.
  • the cost factor is clear, but more important is the fact that the patient is exposed to repeated morbidity and possible mortality and spends valuable time in the hospital away from the family.
  • 5,069,662 also describes a discriminatory treatment of liver cancer.
  • the method described is virtually identical to that described in U.S. Patent No. 4,192,302.
  • the only difference is that catheters are inserted fluoroscopically rather than during an open surgical procedure. Consequently, this procedure also requires multiple hospitalizations and exposes the patient to risks every time the procedure is used (e.g., thrombosis of a vessel, bleeding, damage to the blood vessel such as dissection, etc.).
  • a needle which is suitably marked with indicia to indicate the beveled edge of the needle even when the needle tip is not visible to the practitioner;
  • the needle having two or more lumina to allow the simultaneous introduction of several devices at the same puncture site;
  • a guide-wire of sufficient length so that the practitioner does not come into contact with any part of the wire that has already been in the catheterized system (e.g. bloodstream) .
  • the practitioner inserts the guide-wire into the system then moves it "out” before threading the catheter, thus "touching" potentially contaminated wire;
  • a dilator which is incorporated over the needle to allow dilation of tissues for easy insertion of subsequent device.
  • This dilator is tapered so that dilation occurs in a progressive manner.
  • the dilator has a balloon which, on inflation, allows dilation at the discrimination of the practitioner.
  • the dilator has a tabs for easy maneuverability and also has a self-sealing plug or grommet on the proximal side (i.e., the side closer to the practitioner) ;
  • sheath which is incorporated over the dilator.
  • the sheath is substantially shorter than the dilator and has tabs to allow ease of movement and subsequent securing of the sheath to the skin.
  • the sheath does not communicate with the catheterized system (e.g., bloodstream;
  • the sheath has a self-sealing plug or grommet which may incorporate a bactericidal agent on the proximal end of the sheath;
  • shock sheath which is introduced with or without another catheter through the sheath in emergency situations where multiple ports are required immediately.
  • the shock sheath has multiple lumens for the reasons described in the
  • the sleeve incorporates the entire catheter, including the port limbs and the sheath, leaving only the tabs of the sheath exposed to allow fixation.
  • the sleeve may be in one or two sections and allows repositioning and firm immobilization of the catheter in different positions while maintaining sterility at all times.
  • the sleeve is easily modified for use over a guide- wire or other tool. The catheter is protected at all times. Hence, contamination and catheter damage should be virtually eliminated.
  • Figure 1 is a perspective view of the present surgical instrument
  • Figure 2 is a sectional view taken generally along sectional lines 2-2 of Figure 1;
  • Figure 3 is a sectional view taken generally along sectional lines 3-3 of Figure 2.
  • Figure 4a is a perspective view of the protective sleeve of the present invention
  • Figure 4b is a perspective view of the protective sleeve in a collapsed position
  • Figure 5 is an enlarged view of another embodiment of the dilator shown in Figure 1;
  • Figure 6 is a sectional view of the "shock" sheath of the present invention.
  • Figure 7 is a side view of an adaptation of the protective sleeve for use with a "shock" sheath and a catheter simultaneously;
  • Figure 8 is a side view of a guide-wire, dilator and sheath in place. (Note that the sheath is secured to the skin and does not communicate with the lumen of the blood vessel.);
  • Figure 9 is a side view of a preferred embodiment of the present invention recommended particularly for use endoscopically and also for discriminatory treatment;
  • Figure 10 is a sectional view of yet another embodiment of the invention that can be used for insertion of radioactive seeds
  • Figure 11a is a sectional view of an embodiment of the invention that can be used for the insertion of a catheter containing radioactive seeds
  • Figure lib is a sectional view of the catheter of Figure 11a in place and extending the entire depth of the tumor. Note that any number of such catheters may be inserted in different planes through the tumor mass.
  • Surgical instrument 20 includes a needle 22 having a proximal end 22a and a distal or rear end 22b.
  • Needle 22 can be constructed, for example, of stainless steel or similar material and includes a sharpened (preferably beveled) side 24 of needle end 22a.
  • End 22b of needle 22 is interconnected to a hub 26.
  • hub 26 includes indicia 28 to indicate the direction of beveled side 24 of needle 22.
  • indicia 28 assists the practitioner in locating the position of beveled side 24, while needle 22 is inserted into a blood vessel not visible to or palpable by the practitioner (e.g. subclavian vein - a large blood vessel located under the collarbone in the chest) .
  • Needle 22 includes a first longitudinal bore or lumen 30 and a second longitudinal bore or lumen 32.
  • lumens 30 and 32 are illustrated in Figure 2, it will be understood that the present invention can be utilized with any number of lumens (including one) depending upon the number of guide-wires or tools to be inserted through a single puncture site.
  • First lumen 30 and second lumen 32 originate at beveled side 24 in a parallel relationship, with first lumen 30 and second lumen 32 being separated from each other by an interior wall 34 of needle 22.
  • Lumens 30 and 32 are of sufficient internal diameter to allow passage of guide-wires or other tools used in various procedures in the health care field.
  • Lumen 30 is rectilinear along the entire length of needle 22 and has its terminus 30a at hub 26 of needle 22.
  • Lumen 32 is rectilinear along the substantial longitudinal length of needle 22, with its terminus 32a diverging at an angle from first lumen 30 at hub 26 thereby forming a side arm 38 of needle 22.
  • Hub 26 thereby forms a "Y" connector for use with needle 22. Where it is desired to use several lumens (i.e., more than two) with the needle 22, additional side arms can be utilized in hub 26 such that additional guide- wires or tools can be inserted through needle 22.
  • Hub 26 is constructed of plastic or similar material.
  • Hub 26 is concentrically attached to needle 22 at end 22b and side arm 38 in a manner known and used for the attachment of hub casings of single lumen needles.
  • Hub 26 includes an internal bore 40 which is contiguously aligned with first lumen 30.
  • Hub side arm 38 includes an internal bore 42 which is contiguously aligned with second lumen 32.
  • Bore 40 of hub 26 increases in diameter at bore expansion 44, such that end 40a of bore 40 is adapted to removably engage a standard syringe barrel 46 having a piston 46a and using the inverted frusto-conically shaped aperture 48.
  • Syringe 46 is used for "flash-back", sampling, aspiration and introduction of substances to the catheterized site through lumen 30. Syringe 46 is always in fluid communication with lumen 30 so that there is an uninterrupted communication with the catheterized site.
  • bore 42 terminates in an inverted frusto-conically shaped aperture 50 formed in side arm 38 to facilitate the insertion of a guide-wire 52 into bore 42 and second lumen 32 of needle 22. Bore 42 of side arm 38 is sealingly engaged by a grommet 60.
  • Grommet 60 is constructed of rubber or similar material, and is retained by locking bead 62 of hub 26. Grommet 60 is adapted to be pierced and penetrated by guide-wire 52 (other instrument, tool or device) thereby allowing insertion of guide-wire 52 through grommet 60 and into bore 42 of second lumen 32 while prohibiting the entry of air into or escape of fluid from the catheterized site punctured by beveled end 24 of needle 22.
  • Dilator 70 having ends 70a and 70b.
  • Dilator 70 is tapered at end 70a to approximately the diameter of end 22a of needle 22 and gradually increases in diameter throughout its length to end 70b. Tapering allows a gradual transition in size to accomplish progressive dilation of the opening in the blood vessel (synonymous with any catheterized site in this presentation) and adjacent tissues with subsequent easy insertion of the catheter.
  • end 70b of dilator 70 include wings or tabs 72 to allow easy maneuverability of dilator 70 along the guide-wire 52 and along the needle 22 (this latter may be moved out of position depending on the preference of the practitioner) . Any standard design for wings or tabs can be used. Dilator 70 fits snugly over needle 22 to ensure that there is no trauma to tissue as a result of a sudden transition in size.
  • dilator 70 terminates at end 70a approximately 0.5 to 1.5 cm. from end 22a of needle 22. It is understood that, in general, both the design and length of the dilator can be varied.
  • sheath 80 having ends 80a and 80b.
  • Sheath 80 is circumferentially disposed around dilator 70 and extends from end 70b of dilator 70 to a position between ends 70a and 70b of dilator 70.
  • One embodiment includes wings 82.
  • Other embodiments such as tabs and designs through which sutures are passed can also be used to affix the sheath to the skin 200.
  • sheath 80 makes no contact whatever with the catheterized site (e.g. bloodstream 206). This corrects two major problems encountered during and after catheterization: infection and air embolism.
  • Infection is virtually eliminated because the sheath 80 is not in direct contact with the bloodstream 206 and the catheter 90, inserted through the sheath 80 into the bloodstream 206, is not in contact with skin 200 at any time.
  • This sheath 80 with its self-sealing grommet 86 prevents air embolism while the guide-wire is in place during the process of catheterization.
  • leaving the sheath 80 in place after removal of catheter 90 allows the portion of tract from bloodstream 206 to subcutaneous tissue 202 to heal.
  • the sheath 80 is removed, the only remaining tract extends from skin 200 to subcutaneous tissue 202.
  • the potential for air embolism is virtually eliminated.
  • a protective sleeve 92 which may be preassembled with a catheter 90.
  • the sheath 80 and its parts as already described includes a self-sealing grommet 86 through which a catheter 90 is passed.
  • the catheter has a proximal end 90a and two ports 90b and 90c.
  • the protective sleeve 92 is, in this instance, made of a synthetic soft material capable of being “accordioned. " This sleeve 92 fits circumferentially over the sheath 80 just distal to the tabs 82 of sheath 80 using any sealing mechanism known in the industry (e.g., an "0" ring at location 94a) . It is recommended that the space between tabs 82 and location 94a be the least amount consistent with known manufacturing techniques.
  • Protective sleeve 92 is bonded distally to the ends of the catheter ports
  • the protective sleeve 92 covers the entire system outside the patient's skin 200 with the exception of the tabs 82 for fixation of sheath 80. As discussed earlier, these tabs are not in communication with the catheterized area 206 and cannot become a source of infection.
  • Tabs 96a and 96b on protective sleeve 92 are situated proximally (i.e., nearer sheath 80).
  • Tabs 96a' and 96b* are located distally on protective sleeve 92 (i.e., nearer the ports 90b and 90c of catheter 90).
  • each tab may have an "eye" allowing the passage of a suture to approximate the "accordioned" length of the protective sleeve 92.
  • tab 96a would be attached to tab 96a' and tab 96b' to tab 96b'. Any alternative mechanism of attachment may be used also, such as a clip of adjustable length.
  • Figure 4b shows the protective sleeve 92 "accordioned" by maneuvering it with the catheter 90.
  • the catheter 90 has been repositioned and immobilized in its new position, maintaining complete sterility.
  • tab 96a is now closer to tab 96a' and tab 96b is closer to tab 96b'.
  • Another feature that can be easily added is the bonding to or attaching by any other means the protective sleeve 92 to the catheter 90 at site 98.
  • the material of the protective sleeve 92 can be such that the practitioner can mold the form of protective sleeve 92 and decide exactly how he or she wishes the catheter to lie.
  • this protective sleeve 92 in two parts such that one half is already attached to the sheath 80. This is shown in Figure 7.
  • Protective sleeve 92a incorporates shock sheath 100 with its sidearms 106a and 108a.
  • Protective sleeve 92b incorporates the catheter 90.
  • the protective sleeve 92 as described earlier is easier for the practitioner to use.
  • the dilator 70 has a proximal end 70a and a distal end 70b.
  • Dilator 70 includes a lumen 76.
  • the lumen 78a may be dilated with air, water or other substance to an extent determined by the practitioner.
  • this maneuver be performed after the needle 22 has been optimally situated and the guide-wire inserted. This ensures dilation of tissues only when the practitioner is sure that he or she is ready to insert the catheter or tool. In addition, the practitioner can use the same system without regard to the size of the instrument to be inserted.
  • FIG. 6 is a sectional view of the shock sheath 100 and shows a proximal end 100a and a distal end 100b.
  • a self-sealing grommet 102 is shown through which a tool (e.g., Swan Ganz catheter) may be passed into the isolated lumen 104 of shock sheath 100.
  • a side arm 106a is shown with its own separate lumen 106b. This lumen 106b has a number of side holes 106c on the outside wall distally to allow the infusions of large volumes of fluids.
  • there is a side arm 108a which communicates with its own lumen 108b.
  • the lumen 108b is not in communication with any other lumen and has multiple holes 108c situated distally. This eliminates the possibility of any cross- contamination from the contents of one lumen to the other.
  • Figure 6 is only illustrative. If desired, any number of such side arms and lumens may be incorporated.
  • the lumens may be situated longitudinally or circumferentially to each other.
  • the protective sleeve 92 used will have two parts, 92a and 92b. This device will function according to the principles already described under the description of protective sleeve 92.
  • Figure 7 illustrates use of protective sleeve 92, sheath 80, and shock sheath 100.
  • the shock sheath 100 may have tabs which are easily incorporated on the proximal end (i.e., the side towards the practitioner). Antiseptic, bactericidal and other agents may be used to coat or be incorporated into either part of the system or the whole system.
  • Procedure for Catheterization The practitioner positions the needle 22 such that the indicia 28 faces the side he or she wishes the guide- wire 52 to exit the needle tip 22a. This is important because it determines the initial course the guide-wire 52 will take in the lumen of the vessel 206 (e.g., the subclavian vein) and dictates the direction of the catheter. Guide-wire 52 pierces grommet 60 and passes into hub 26. The wire exits the needle tip 22a by passing through bore 42 into lumen 32. The practitioner observes continuous flash-back in syringe 46 throughout this procedure.
  • the dilator 70 and sheath 80 are maneuvered simultaneously along the guide-wire 52 into blood vessel lumen 206 as the needle 22 with the attached syringe 46 is removed from the puncture site.
  • Tabs 82 of sheath 80 are sutured to the skin 200.
  • Figure 8 illustrates this.
  • the dilator 70 is removed and the catheter 90 with the protective sleeve 92 is "threaded" over the guide- wire 52 into the vessel.
  • the protective sleeve 92 is secured at 94a.
  • Tab 96a is attached to tab 96a' and tab 96b to tab 96b'.
  • a small dressing may be applied or a little tincture benzoin sprayed around the area. This is a comprehensive, safe and efficient system.
  • flash-back this procedure should take less than one minute to perform. Further care of the catheter and catheterization site is safe (the device cannot be dislodged), infection-free and economical. Definitive diagnosis of many diseases is obtained by a biopsy. Often the practitioner obtains a sample from the tissue in two steps. The practitioner first aspirates the site to be sure it is not a blood vessel. Once this is ascertained, the lesion is biopsied. Using instrument 20, the lesion is entered with the needle 22 and syringe 46 is used for "flash-back.” If no blood is observed, a biopsy forcep is introduced through the side arm 38 of the "Y" connector (as was guide-wire 52 above) and a sample of tissue obtained. There are many different biopsy instruments available to choose from.
  • Surgical instrument 20 can be used endoscopically to catheterize the specific blood vessel entering the cancerous organ or even the blood vessel entering the specific part of the organ with cancer.
  • Figure 9 shows a preferred embodiment. Needle 22 is used to puncture the blood vessel and free "flash ⁇ back" ascertained with the syringe 46 as before.
  • Guide- wire 52 is inserted into the lumen of the blood vessel and the catheter 90 is threaded immediately into the lumen of the blood vessel.
  • the "Y" connector and the syringe are not depicted in this figure for clarity.
  • the catheter 90 which has side holes 160 is already in place over the needle 22 at the start of the procedure. This is accomplished by inserting needle 22 through a self-sealing grommet 110 on the side wall of the catheter where grommet 110 can also be a functional side hole of the catheter. It is recommended that the aperture 110 be located close to the distal tip of the catheter. This embodiment is particularly recommended for use endoscopically (e.g. laparoscopically) .
  • the catheter is attached to any of the many available subcutaneous ports and therapeutic agents instilled in the port as desired without any need for subsequent hospitalizations.
  • Another embodiment includes dilator 70.
  • the dilator 70 be made of a biodegradable material, so that the dilator can be left in the body at the practitioner's discretion. This procedure requires minimal, if any, hospitalization; is safe, efficient, is discriminatory, and allows treatment at home.
  • Figure 10 illustrates the use of surgical instrument 20 in providing discriminatory treatment by inserting the therapeutic agent directly into the cancer.
  • the lesion is punctured with the needle 22, lack of "flash-back" is observed in syringe 46 and radiation seeds 112 are inserted through the Y connector 38 in lieu of guide-wire 52.
  • This procedure is repeated at different sites on and in the tumor. It is recommended that the needle 22 be marked along its length so that the practitioner varies depth of the needle 22 at different sites within the tumor mass.
  • the insertion of the radiation seeds 112 can be accomplished in several ways and includes (a) maneuvering them along the lumen 32a with a wire or other instrument or (b) using an ejection gun 126 to displace the seeds. If the latter is the preferred method, this invention may be used with multiple needles 22 (instead of just one) as shown in Figure 10.
  • This invention allows catheterization to be performed anywhere on or in the body (i.e., it is universal); any type of catheterization can be accomplished (i.e, it is uniform); diagnosis and treatment can be performed at the same time using one procedure (i.e., the invention is comprehensive); discriminatory treatment is allowed with minimal or no hospitalization; risk to the patient is reduced; cost to the patient as well as to the health care industry.is reduced; the invention improves the quality of life for the patient and should increase his or her length of survival; catheterization is achieved without the multiple problems discussed in the BACKGROUND OF THE INVENTION.

Abstract

Un système et un procédé de sondage comprennent l'utilisation d'une aiguille (22), d'un raccord en 'Y' (28), d'une seringue (46), d'un dilatateur (70), d'une gaine (80), d'un fourreau protecteur (92) et d'une gaine d'urgence (100). Ce système représente une approche complète, généralisée et universelle au sondage. Des procédés de traitement localisé au moyen de cette invention sont décrits. On a tout particulièrement pris en considération les problèmes courants impliqués dans les procédés de sondage, ainsi que la prévention de la transmission de maladies contagieuses entre médecin et patient (le risque de transmission du virus VIH, notamment, est sensiblement réduit grâce à ce système). L'invention permet également de réduire considérablement le coût des soins de santé tout en améliorant l'efficacité du diagnostic et du traitement. Elle permet au médecin de diagnostiquer et de traiter simultanément des maladies en utilisant le même procédé, indépendamment de l'endroit où la maladie s'est déclarée, dans ou sur le corps. La durée de l'hospitalisation ainsi que le nombre d'hospitalisations requises sont réduits au minimum, et la qualité de vie du patient est améliorée tandis que sa durée de vie est prolongée.
PCT/US1993/009501 1992-07-27 1993-10-05 Instrument de sondage WO1995009662A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US07/919,912 US5257979A (en) 1992-07-27 1992-07-27 Instrument for catheterization
PCT/US1993/009501 WO1995009662A1 (fr) 1992-07-27 1993-10-05 Instrument de sondage
AU53522/94A AU5352294A (en) 1992-07-27 1993-10-05 Instrument for catheterization

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/919,912 US5257979A (en) 1992-07-27 1992-07-27 Instrument for catheterization
PCT/US1993/009501 WO1995009662A1 (fr) 1992-07-27 1993-10-05 Instrument de sondage

Publications (1)

Publication Number Publication Date
WO1995009662A1 true WO1995009662A1 (fr) 1995-04-13

Family

ID=26787054

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/009501 WO1995009662A1 (fr) 1992-07-27 1993-10-05 Instrument de sondage

Country Status (1)

Country Link
WO (1) WO1995009662A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022204049A1 (fr) * 2021-03-22 2022-09-29 Bard Access Systems, Inc. Aiguille de distribution polyvalente

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540404A (en) * 1983-01-19 1985-09-10 Datascope Corp. Balloon catheter with intrinsic introducer for percutaneous insertion into a blood vessel over a guide wire, and method of use
US4652256A (en) * 1985-10-29 1987-03-24 Manresa, Inc. Closed system catheter with guide wire
US4654031A (en) * 1985-04-15 1987-03-31 Warner-Lambert Company Flash chamber
US4935008A (en) * 1988-07-20 1990-06-19 Lewis Jr Ronald L Double lumen introducing needle
US5011478A (en) * 1989-01-31 1991-04-30 Cook Incorporation Recessed dilator-sheath assembly and method
US5205829A (en) * 1990-02-09 1993-04-27 Lituchy Andrew E Safety disposable intravenous (I.V. assembly)

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540404A (en) * 1983-01-19 1985-09-10 Datascope Corp. Balloon catheter with intrinsic introducer for percutaneous insertion into a blood vessel over a guide wire, and method of use
US4654031A (en) * 1985-04-15 1987-03-31 Warner-Lambert Company Flash chamber
US4652256A (en) * 1985-10-29 1987-03-24 Manresa, Inc. Closed system catheter with guide wire
US4935008A (en) * 1988-07-20 1990-06-19 Lewis Jr Ronald L Double lumen introducing needle
US5011478A (en) * 1989-01-31 1991-04-30 Cook Incorporation Recessed dilator-sheath assembly and method
US5205829A (en) * 1990-02-09 1993-04-27 Lituchy Andrew E Safety disposable intravenous (I.V. assembly)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022204049A1 (fr) * 2021-03-22 2022-09-29 Bard Access Systems, Inc. Aiguille de distribution polyvalente

Similar Documents

Publication Publication Date Title
US5257979A (en) Instrument for catheterization
US5695479A (en) Instrument, system, kit and method for catheterization procedures
CN213252379U (zh) 用于进入患者的脉管系统的导管组件
EP3877019B1 (fr) Système de cathéter
JP2910916B2 (ja) カテーテルと誘導針とのアセンブリ
US5078688A (en) Paracentesis catheter system
US3782381A (en) Method for preventing skiving of a catheter
US5290244A (en) Syringe and needle with guide wire for cannulation of central veins
US7736336B2 (en) Paracentesis device having multiple detachable components
JP3586424B2 (ja) カテーテル導入器
JP7315915B2 (ja) 穿刺システム
US6139522A (en) Electrophysiology positioning catheter
US3885561A (en) Catheter
US5833662A (en) Hemostasis cannula system
US20110152836A1 (en) Method and Apparatus for Arterial and Venous Cannulation
JP2004526481A (ja) 取付け可能なハブを有する多内腔カテーテル
JPH08257129A (ja) カテーテルと導入針とのアセンブリ
JP7313698B2 (ja) 穿刺システム
JP2005519679A (ja) 中心静脈カテーテル法または動脈カテーテル法のためのニードル・拡張器組み合わせ装置
CA2649260A1 (fr) Dispositif de penetration par effet tunnel de tissu mou
CA2818600C (fr) Canule a autodilatation
US20020049414A1 (en) Fluid delivery and extraction device and method
WO1995009662A1 (fr) Instrument de sondage
CA2173443A1 (fr) Instrument de sondage
US8882715B2 (en) Catheterization device and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2173443

Country of ref document: CA

122 Ep: pct application non-entry in european phase